NASDAQ: TGTX
Tg Therapeutics Inc Stock Ownership - Who owns Tg Therapeutics?

Insider buying vs selling

Have Tg Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Yann EchelardDirector2025-11-245,000$32.57
$162.85kSell
Sagar LonialDirector2025-09-1120,852$32.24
$672.27kSell
Yann EchelardDirector2025-06-1310,000$36.94
$369.40kSell

1 of 1

TGTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TGTX insiders and whales buy or sell their stock.

TGTX Shareholders

What type of owners hold Tg Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael S. Weiss21.14%33,760,975$947.00MInsider
Blackrock Inc13.68%21,848,462$612.85MInstitution
Vanguard Group Inc9.92%15,841,002$444.34MInstitution
Ra Capital Management LP7.91%12,629,868$354.27MInsider
Lindsay A. Md Rosenwald5.93%9,462,616$265.43MInsider
State Street Corp5.31%8,479,999$237.86MInstitution
Biotechnologies Sasu Lfb4.77%7,614,855$213.60MInsider
Joan Pons Gimbert2.48%3,959,149$111.05MInsider
Clearbridge Investments LLC2.16%3,448,033$96.72MInstitution
Geode Capital Management LLC2.13%3,403,866$95.48MInstitution

1 of 3

TGTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TGTX58.12%41.88%Net Selling
LGND18.32%81.68%Net SellingNet Selling
ERAS71.82%28.18%Net BuyingNet Buying
VKTX62.25%8.90%Net SellingNet Selling
FOLD66.65%33.35%Net SellingNet Selling

Tg Therapeutics Stock Ownership FAQ

Who owns Tg Therapeutics?

Tg Therapeutics (NASDAQ: TGTX) is owned by 64.72% institutional shareholders, 46.63% Tg Therapeutics insiders, and 0.00% retail investors. Michael S. Weiss is the largest individual Tg Therapeutics shareholder, owning 33.76M shares representing 21.14% of the company. Michael S. Weiss's Tg Therapeutics shares are currently valued at $909.52M.

If you're new to stock investing, here's how to buy Tg Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.